| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |